Striatal dopaminergic dysfunction in LRRK2 mutations models the progression of sporadic Parkinson's disease

被引:0
|
作者
Agarwal, P.
Mak, E.
Schulzer, M.
Dinelle, K.
Aasly, J.
Hasegawa, K.
Wszolek, Z.
Zhang, J.
McKenzie, J.
Heffernan, N.
Farrer, M.
Sossi, V.
Stoessl, A. J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
121
引用
收藏
页码:S47 / S47
页数:1
相关论文
共 50 条
  • [31] Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
    G. A. Smith
    J. Jansson
    E. M. Rocha
    T. Osborn
    P. J. Hallett
    O. Isacson
    Molecular Neurobiology, 2016, 53 : 5161 - 5177
  • [32] Co existence of the LRRK2 and GBA mutations in Parkinson's disease
    Kestenbaum, M.
    Gurevich, T.
    Mirelman, A.
    Levi, S.
    Gan-Or, Z.
    Orr-Urtreger, A.
    Giladi, N.
    JOURNAL OF NEUROLOGY, 2011, 258 : 199 - 199
  • [33] LRRK2 mutations in Basque patients with Parkinson's disease -: Reply
    Healy, Daniel G.
    LANCET NEUROLOGY, 2008, 7 (10): : 867 - 867
  • [34] LRRK2 mutations in patients with Parkinson's disease in southern Spain
    Mir, P.
    Gao, L.
    Diaz, F.
    Carrillo, F.
    Carballo, M.
    Palomino, A.
    Diaz-Martin, J.
    Mejias, R.
    Vime, P. J.
    Pintado, E.
    Lucas, M.
    Lopez-Barneo, J.
    MOVEMENT DISORDERS, 2007, 22 : S129 - S129
  • [35] Genetic analysis of LRRK2 mutations in patients with Parkinson's disease
    Deng, H
    Le, W
    Guo, Y
    Hunter, C
    Xie, W
    Jankovic, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S361 - S362
  • [36] Mitochondrial impairment in Parkinson's disease patients with LRRK2 mutations
    Arns, B.
    Meier, B.
    Klein, C.
    Gruenewald, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 846 - 846
  • [37] Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition
    Smith, G. A.
    Jansson, J.
    Rocha, E. M.
    Osborn, T.
    Hallett, P. J.
    Isacson, O.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (08) : 5161 - 5177
  • [38] LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease
    Elbaz, Alexis
    LANCET NEUROLOGY, 2008, 7 (07): : 562 - 564
  • [39] Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2
    Deshpande, Prasannakumar
    Flinkman, Dani
    Hong, Ye
    Goltseva, Elena
    Siino, Valentina
    Sun, Lihua
    Peltonen, Sirkku
    Elo, Laura L.
    Kaasinen, Valtteri
    James, Peter
    Coffey, Eleanor T.
    FASEB JOURNAL, 2020, 34 (11): : 14217 - 14233
  • [40] LRRK2 mutations are a common cause of Parkinson's disease in Spain
    Mata, IF
    Ross, OA
    Kachergus, J
    Huerta, C
    Ribacoba, R
    Moris, G
    Blazquez, M
    Guisasola, LM
    Salvador, C
    Martinez, C
    Farrer, M
    Alvarez, V
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (04) : 391 - 394